14/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Scientific Data Research Center

14/14 APOL1长期肾移植结果网络(APOLLO)科学数据研究中心

基本信息

  • 批准号:
    10728589
  • 负责人:
  • 金额:
    $ 90.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-25 至 2028-05-31
  • 项目状态:
    未结题

项目摘要

The NIH APOL1 Long-term Transplantation Outcomes Network (APOLLO) Collaborative U01 is performing a national prospective evaluation of donor and recipient apolipoprotein L1 gene (APOL1) risk variants in US kidney transplants from African American donors to determine their effect on transplant outcomes. In addition, post- donation health and kidney function of African American living kidney donors will be assessed. We are applying to continue serving as the APOLLO Scientific and Data Research Center (SDRC). Shorter renal allograft survival is observed for transplantations from deceased African American kidney donors, relative to deceased European American kidney donors. Reasons for this are unknown, but retrospective reports suggest that presence of two APOL1 risk variants in kidney donors may contribute to the disparity. These variants are common in populations with recent African ancestry (such as African Americans), where they are strongly associated with chronic kidney disease, but rare in other racial/ethnic groups. APOL1 genotype data may provide more accurate assessment of the likelihood for long-term renal allograft function in donor kidneys, thereby improving matching of donor kidneys with potential recipients in order to optimize renal allograft and patient survival. This information may better inform physicians about organ quality prior to making decisions on allocation. It may also inform the safety of living kidney donation. Before APOL1 genotypes can be used clinically, the prospective national APOLLO study was required to evaluate kidney transplant outcomes from African American donors and recipients of their kidneys based on APOL1. APOLLO collects information lacking from retrospective studies, including recipient APOL1 genotypes, renal histology in engrafted kidneys and presence or development of BK viral infections, donor specific antibodies, and acute rejections after kidney transplantation. We apply to continue to perform these activities for the APOLLO Network: overall study coordination, assist with ensuring compliance with the Protocol and Manual of Procedures, maintain data tracking tools and the study website, collect and archive clinical and outcomes data, perform genotyping, statistical analyses, assessment of outcomes including the primary outcome “time to allograft failure in transplanted kidneys from African American donors based on donor APOL1 genotypes”, and complete the bio-repository. We will longitudinally assess vital status, kidney function and proteinuria in living African American kidney donors based on APOL1 genotypes and prospectively assess effects of donor APOL1 genotypes on serum creatinine concentration, estimated glomerular filtration rate, and proteinuria in kidney transplant recipients with functioning grafts. APOLLO results have the potential to transform the organ allocation and informed consent processes in kidney transplantation, optimize renal allograft survival, reduce discard of good-quality kidneys, and protect the health of living kidney donors.
美国国立卫生研究院APOL1长期移植结果网络(APOLLO)合作U01正在进行一项研究

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (pro).
  • DOI:
    10.1016/j.kint.2020.11.025
  • 发表时间:
    2021-07
  • 期刊:
  • 影响因子:
    19.6
  • 作者:
    Freedman BI;Poggio ED
  • 通讯作者:
    Poggio ED
Recipient APOL1 Genotype Effects on Outcomes After Kidney Transplantation.
受者 APOL1 基因型对肾移植后结果的影响。
Mechanisms of Injury in APOL1-associated Kidney Disease.
  • DOI:
    10.1097/tp.0000000000002509
  • 发表时间:
    2019-03
  • 期刊:
  • 影响因子:
    6.2
  • 作者:
    Ma L;Divers J;Freedman BI
  • 通讯作者:
    Freedman BI
Impact of education on APOL1 testing attitudes among prospective living kidney donors.
  • DOI:
    10.1111/ctr.14516
  • 发表时间:
    2022-01
  • 期刊:
  • 影响因子:
    2.1
  • 作者:
  • 通讯作者:
Integrating APOL1 Kidney-risk Variant Testing in Live Kidney Donor Evaluation: An Expert Panel Opinion.
  • DOI:
    10.1097/tp.0000000000003641
  • 发表时间:
    2021-10-01
  • 期刊:
  • 影响因子:
    6.2
  • 作者:
    Doshi MD;Gordon EJ;Freedman BI;Glover C;Locke JE;Thomas CP
  • 通讯作者:
    Thomas CP
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DONALD W BOWDEN其他文献

DONALD W BOWDEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DONALD W BOWDEN', 18)}}的其他基金

Wake Forest APOLLO Scientific and Data Research Center
维克森林阿波罗科学与数据研究中心
  • 批准号:
    9975002
  • 财政年份:
    2017
  • 资助金额:
    $ 90.1万
  • 项目类别:
Wake Forest APOLLO Scientific and Data Research Center
维克森林阿波罗科学与数据研究中心
  • 批准号:
    10215268
  • 财政年份:
    2017
  • 资助金额:
    $ 90.1万
  • 项目类别:
Wake Forest APOLLO Scientific and Data Research Center
维克森林阿波罗科学与数据研究中心
  • 批准号:
    9440610
  • 财政年份:
    2017
  • 资助金额:
    $ 90.1万
  • 项目类别:
Wake Forest APOLLO Scientific and Data Research Center
维克森林阿波罗科学与数据研究中心
  • 批准号:
    10475327
  • 财政年份:
    2017
  • 资助金额:
    $ 90.1万
  • 项目类别:
Wake Forest APOLLO Scientific and Data Research Center
维克森林阿波罗科学与数据研究中心
  • 批准号:
    10490832
  • 财政年份:
    2017
  • 资助金额:
    $ 90.1万
  • 项目类别:
Metabolomic Signatures of CAD Associated Genotypes
CAD 相关基因型的代谢组学特征
  • 批准号:
    9172683
  • 财政年份:
    2016
  • 资助金额:
    $ 90.1万
  • 项目类别:
Metabolomic Signatures of CAD Associated Genotypes
CAD 相关基因型的代谢组学特征
  • 批准号:
    9334928
  • 财政年份:
    2016
  • 资助金额:
    $ 90.1万
  • 项目类别:
Exome Sequencing to Identify CVD Risk Variants in Hispanics & African Americans
外显子组测序识别西班牙裔 CVD 风险变异
  • 批准号:
    8464763
  • 财政年份:
    2012
  • 资助金额:
    $ 90.1万
  • 项目类别:
Exome Sequencing to Identify CVD Risk Variants in Hispanics & African Americans
外显子组测序识别西班牙裔 CVD 风险变异
  • 批准号:
    8507934
  • 财政年份:
    2012
  • 资助金额:
    $ 90.1万
  • 项目类别:
Exome Sequencing to Identify CVD Risk Variants in Hispanics & African Americans
外显子组测序识别西班牙裔 CVD 风险变异
  • 批准号:
    8660319
  • 财政年份:
    2012
  • 资助金额:
    $ 90.1万
  • 项目类别:

相似海外基金

Un/kindness, shame & resistance: the care of inpatients in NHS adult acute mental health units and how it might be improved
Un/善良,羞耻
  • 批准号:
    2885806
  • 财政年份:
    2023
  • 资助金额:
    $ 90.1万
  • 项目类别:
    Studentship
Post-Acute Care Transitions for Older Adult Medicare Beneficiaries with Serious Mental Illness
患有严重精神疾病的老年医疗保险受益人的急性后护理过渡
  • 批准号:
    10772386
  • 财政年份:
    2023
  • 资助金额:
    $ 90.1万
  • 项目类别:
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
  • 批准号:
    474619
  • 财政年份:
    2022
  • 资助金额:
    $ 90.1万
  • 项目类别:
    Operating Grants
Investigating the impact acute inhalation of cannabis with a high content of delta-9-tetrahydrocannabinol has on myelination and microglia in adult and aged mice
研究急性吸入高含量 delta-9-四氢大麻酚的大麻对成年和老年小鼠髓鞘形成和小胶质细胞的影响
  • 批准号:
    485965
  • 财政年份:
    2022
  • 资助金额:
    $ 90.1万
  • 项目类别:
    Studentship Programs
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
  • 批准号:
    466358
  • 财政年份:
    2022
  • 资助金额:
    $ 90.1万
  • 项目类别:
    Operating Grants
Metabolomics for prediction of cisplatin mediated acute kidney injury: a Canadian multi-centre adult and pediatric study
预测顺铂介导的急性肾损伤的代谢组学:加拿大多中心成人和儿童研究
  • 批准号:
    402040
  • 财政年份:
    2019
  • 资助金额:
    $ 90.1万
  • 项目类别:
    Operating Grants
Study of pathogenic mechanism of age-dependent chromosome translocation in adult acute lymphoblastic leukemia
成人急性淋巴细胞白血病年龄依赖性染色体易位发病机制研究
  • 批准号:
    18K16103
  • 财政年份:
    2018
  • 资助金额:
    $ 90.1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Causal effect of time-varying driving pressures on mortality in mechanically ventilated, adult patients with acute respiratory distress syndrome
时变驱动压力对机械通气成年急性呼吸窘迫综合征患者死亡率的因果影响
  • 批准号:
    377313
  • 财政年份:
    2017
  • 资助金额:
    $ 90.1万
  • 项目类别:
    Studentship Programs
Role of SETBP1 in adult Ph+ acute lymphoblastic leukemia
SETBP1 在成人 Ph 急性淋巴细胞白血病中的作用
  • 批准号:
    9315111
  • 财政年份:
    2016
  • 资助金额:
    $ 90.1万
  • 项目类别:
Acute Inhibition of Adult-born Granule Cells and its Effect on Antidepressant Act
成体颗粒细胞的急性抑制及其抗抑郁作用
  • 批准号:
    8734273
  • 财政年份:
    2013
  • 资助金额:
    $ 90.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了